Skip to main content
Top

Current Oncology Reports

Issue 12/2022

Content (22 Articles)

Surgery Gynecologic Cancers (NS Reed, Section Editor)

Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review

Delphine Hudry, Stéphanie Bécourt, Giovanni Scambia, Anna Fagotti

Ovarian Cancer Gynecologic Cancers (NS Reed, Section Editor)

Targeting the PI3K Pathway in Gynecologic Malignancies

Monica Avila, Michaela Onstad Grinsfelder, Melissa Pham, Shannon N. Westin

Endometrial Cancer Gynecologic Cancers (NS Reed, Section Editor)

Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy

Julia Dexter, Erin Lips, Paul DiSilvestro

Ovarian Cancer Gynecologic Cancers (NS Reed, Section Editor)

Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse

Christina R. Washington, Kathleen N. Moore

Alopecia Geriatric Oncology (L Balducci, Section Editor)

New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology

Lodovico Balducci, Claire Falandry, Alan List

Chronic Lymphocytic Leukemia Geriatric Oncology (L Balducci, Section Editor)

How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?

Joanna M. Rhodes, Jacqueline C. Barrientos, Kanti R. Rai

Care Integrative Care (M Frenkel, Section Editor)

Art Therapy in Advanced Cancer. A Mapping Review of the Evidence

Nadia Collette, Ivan Sola, Xavier Bonfill, Antonio Pascual

Computed Tomography Interventional Oncology (DC Madoff, Section Editor)

Role of Interventional Radiology in Pediatric Cancer Patients

Allison Aguado

Open Access Cardiomyopathy Cardio-oncology (JN Upshaw, Section Editor)

Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology

Yali Deng, Doan T. M. Ngo, Jessica K. Holien, Jarmon G. Lees, Shiang Y. Lim

Cardiomyopathy Cardio-oncology (JN Upshaw, Section Editor)

Cardio-Oncology in Childhood: State of the Art

Elena Bennati, Francesca Girolami, Gaia Spaziani, Giovanni Battista Calabri, Claudio Favre, Iris Parrini, Fabiana Lucà, Angela Tamburini, Silvia Favilli

Systemic Therapy Breast Cancer (RA Leon Ferre, Section Editor)

Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications

Prarthna V. Bhardwaj, Yara G. Abdou

Breast Cancer Breast Cancer (RA Leon Ferre, Section Editor)

Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer

Mónica Cejuela, Andrea Vethencourt, Sonia Pernas

Cholangiocarcinoma Gastrointestinal Cancers (J Meyer, Section Editor)

Immunotherapy in Biliary Tract Cancers: Where Are We?

Aparna Kalyan, Harshit Khosla, Richard D. Kim

NSCLC Lung Cancer (H Borghaei, Section Editor)

Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic Class

Jennifer A. Marks, Molly Wilgucki, Stephen V. Liu, Joshua E. Reuss

Care Lung Cancer (H Borghaei, Section Editor)

Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?

Howard (Jack) West, Afsaneh Barzi, Debra Wong

NSCLC Lung Cancer (H Borghaei, Section Editor)

Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer

Giuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, Veronica Mollica, Alessio Cortellini, Sara Elena Rebuzzi, Arsela Prelaj, Abdul Rafeh Naqash, Edouard Auclin, Lucia Garetto, Laura Mezquita, Alfredo Addeo

Lymphoma Lymphomas (T Hilal, Section Editor)

Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider’s Perspective

Ginna Granroth, Allison Rosenthal, Maggie McCallen, Christopher Coughlin, Hollie Benson, Jeanne Palmer, Januario E. Castro, Javier Munoz

Melanoma Melanoma (DB Johnson, Section Editor)

Targeted Therapy for Melanomas Without BRAF V600 Mutation

Jacob S. Choi, Sunandana Chandra

Correction

Correction to: Art Therapy in Advanced Cancer. A Mapping Review of the Evidence

Nadia Collette, Ivan Sola, Xavier Bonfill, Antonio Pascual

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine